1. Home
  2. HLMN vs CAPR Comparison

HLMN vs CAPR Comparison

Compare HLMN & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.44

Market Cap

1.5B

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$24.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
CAPR
Founded
1964
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
HLMN
CAPR
Price
$8.44
$24.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$11.60
$44.63
AVG Volume (30 Days)
2.1M
1.3M
Earning Date
04-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
122.22
N/A
EPS
N/A
N/A
Revenue
$1,552,224,000.00
N/A
Revenue This Year
$7.65
N/A
Revenue Next Year
$4.67
$3.31
P/E Ratio
N/A
N/A
Revenue Growth
5.41
N/A
52 Week Low
$6.96
$4.30
52 Week High
$10.85
$40.37

Technical Indicators

Market Signals
Indicator
HLMN
CAPR
Relative Strength Index (RSI) 65.30 36.35
Support Level $7.76 $22.09
Resistance Level $8.59 $25.70
Average True Range (ATR) 0.32 1.52
MACD 0.10 -0.16
Stochastic Oscillator 95.31 8.17

Price Performance

Historical Comparison
HLMN
CAPR

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: